Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Nov 13 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the closure of a USFDA inspection at its oncology injectable manufacturing facility in Ahmedabad. The inspection, which took place over several days, resulted in two observations, but no data integrity issues were noted. The company plans to work closely with the USFDA to address these observations promptly.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Closure of USFDA inspection at Zydus oncology injectable manufacturing facility in SEZ1, Ahmedabad".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases